Global Comparison of COVID-19 Vaccination Rates among Psoriasis Patients

被引：0

作者：

Korouri, Edwin ^{[1
]}

Jeong, Charlotte ^{[2
]}

Peterson, Hannah ^{[3
]}

Valenzuela, Fernando ^{[4
,5
]}

Romiti, Ricardo ^{[6
]}

Didaskalu, Johannes A. ^{[7
]}

Egeberg, Alexander ^{[8
,9
]}

Oon, Hazel H. ^{[10
,11
]}

Maul, Lara Valeska ^{[7
,12
]}

Kingston, Paige ^{[3
]}

Lee, Kathryn ^{[3
]}

Huang, Margaret Y. ^{[3
]}

Yee, Danielle ^{[3
]}

Artiga, Kevin ^{[3
]}

Aguero, Rosario ^{[13
]}

Maul, Julia-Tatjana ^{[7
,12
]}

Armstrong, April W. ^{[3
]}

机构：

[1] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA

[2] Univ Arkansas Med Sci, Coll Med, Little Rock, AR 72205 USA

[3] Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA

[4] Univ Chile, Dept Dermatol, Santiago 8330111, Chile

[5] Prob Med Res, Ctr Int Estudios Clin, Santiago 8420383, Chile

[6] Univ Sao Paulo, Sch Med, Dept Dermatol, Sao Paulo, Brazil

[7] Univ Zurich, Fac Med, CH-8006 Zurich, Switzerland

[8] Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark

[9] Univ Copenhagen, Dept Clin Med, DK-1172 Copenhagen, Denmark

[10] Natl Skin Ctr, Singapore 308205, Singapore

[11] Skin Res Inst Singapore SRIS, Singapore 308232, Singapore

[12] Univ Hosp Zurich, Dept Dermatol, CH-8091 Zurich, Switzerland

[13] Univ Southern Calif, Keck Sch Med, Dept Populat & Publ Hlth Sci, Los Angeles, CA 90007 USA

来源：

LIFE-BASEL | 2024年 / 14卷 / 10期

关键词：

psoriasis; biologics; vaccination; global; COVID-19; EUROGUIDERM GUIDELINE; SYSTEMIC TREATMENT; VULGARIS; SAFETY;

D O I：

10.3390/life14101297

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

(1) Background: The purpose of this study is to compare the rate of COVID-19 vaccination among psoriasis patients internationally and to correlate it with their treatment regimens. (2) Methods: We conducted a cross-sectional study from January 2021 to October 2022 among adults in the United States (US), Chile, China, Switzerland, and Singapore using the Global Healthcare Study on Psoriasis survey. (3) Results: A total of 310 psoriasis patients in the US (98), Chile (32), China (80), Switzerland (39), and Singapore (61) were surveyed. Of these, 248 patients (80.0%) were vaccinated at least once for COVID-19 (Chile: 100%, Singapore: 100%, US: 93.9%, Switzerland: 69.2%, China: 45.0%). Compared with other countries, patients in China were 89% less likely to report at least one COVID-19 vaccination (1 - 0.11 = 0.89; OR 0.11; 95% CI: 0.03-0.48), and patients in Switzerland were 80% less likely (1 - 0.20 = 0.80; OR 0.20; 95% CI: 0.05-0.79). Compared with patients on biologics, patients on topicals were 10.9 (95% CI: 2.1-56.6) times more likely to report at least one COVID-19 vaccination, and patients on oral systemics were 7.2 times more likely (95% CI: 1.6-31.6). (4) Conclusions: Country of residence and treatment regimen are associated with different COVID-19 vaccination rates in psoriasis patients.

引用

页数：15